Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients
Transfusion · 2023
DOI: 10.1111/trf.17529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von G Sotolongo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Duke University Hospital, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Anemia, Aplastic, Primary Myelofibrosis, Blood Group Antigens, Anemia, Hemolytic, Autoimmune. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Red blood cell (RBC) alloimmunization (AI) is a well‐known complication of RBC transfusions, which results in the formation of alloantibodies to non‐self antigens on donor RBCs, putting patients at risk of transfusion‐related complications. The rate of AI with RBC transfusions in the general hospitalized population is estimated to be 2%–3%. However, some patients who are deemed “transfusion‐dependent” require regular transfusions of blood products due to persistently low cell counts, putting them at even greater risk of RBC AI and increased morbidity. However, few studies currently exist investigating RBC AI in some transfusion‐dependent patient populations, e.g., aplastic anemia (AA) and myelofibrosis (MF). Study Design and Methods We conducted a 5‐year retrospective review to investigate the prevalence of RBC AI, alloantibody incidence, and the number of RBC transfusions in AA and MF patients, who received RBC transfusions within our hospital system.
Results
During the study period, 64 AA and 93 MF patients received 1301 and 2766 RBC transfusions, respectively. Compared to the RBC AI rate in the generalized hospitalized patient population (1%–2%), patients with AA and MF had an increased rate of RBC AI incidence rate at 14.1% and 12.9%, respectively. Furthermore, patients with primary MF demonstrated an isolated increased RBC AI incidence rate of 13.3%. The most common alloantibodies produced were anti‐E and anti‐K.
Discussion
Within our institution, patients with AA and MF had increased incidence rates of RBC AI compared to the general hospitalized patient population and may benefit from an antigen‐matched protocol to minimize AI‐related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Duke University Hospital, Durham, North Carolina, USA.
ORCID-Profile: G Sotolongo
Zitieren
APA
Sotolongo, G., & Poisson, J. L. (2023). Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients. Transfusion. https://doi.org/10.1111/trf.17529
Vancouver
Sotolongo G, Poisson JL. Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients. Transfusion. 2023. doi:10.1111/trf.17529
BibTeX
@article{Sotolongo2023,
author = {Sotolongo, G and Poisson, J L},
title = {Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17529}
}
EUVIMED